Anifrolumab, a relatively new monoclonal antibody, is sparking considerable excitement within the medical community as a potential option for various immune-related disorders. This innovative medication targets the https://brianomcc396268.mpeblog.com/73978762/anifrolumab-a-promising-treatment-for-autoimmune-illnesses